Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17458 | 598 | 47.0 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
482 | 3 | MULTIPLE MYELOMA//AMYLOIDOSIS//TRANSTHYRETIN | 23544 |
713 | 2 | MULTIPLE MYELOMA//MYELOMA//LENALIDOMIDE | 12863 |
17458 | 1 | MYELOMA BONE DISEASE//MULTIPLE MYELOMA//BONE DISEASE | 598 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MYELOMA BONE DISEASE | authKW | 658313 | 3% | 68% | 19 |
2 | MULTIPLE MYELOMA | authKW | 341703 | 37% | 3% | 219 |
3 | BONE DISEASE | authKW | 288041 | 8% | 12% | 46 |
4 | COLLAGEN DERIVED PEPTIDES | authKW | 153184 | 1% | 100% | 3 |
5 | MYELOMA | authKW | 139955 | 12% | 4% | 70 |
6 | MYELOMA THER Y | address | 132564 | 5% | 8% | 31 |
7 | GENET MICROORGANISM BIOL ANTHROPOL EVOLUT | address | 102123 | 0% | 100% | 2 |
8 | HAEMATOLROYAL ADELAIDE HOSP | address | 102123 | 0% | 100% | 2 |
9 | MM INDUCED BONE DISEASE | authKW | 102123 | 0% | 100% | 2 |
10 | CLIN THER EUT INTERNAL MED | address | 91908 | 1% | 60% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 14408 | 47% | 0% | 282 |
2 | Oncology | 2728 | 36% | 0% | 213 |
3 | Endocrinology & Metabolism | 199 | 8% | 0% | 49 |
4 | Medicine, Research & Experimental | 125 | 7% | 0% | 39 |
5 | Cell & Tissue Engineering | 59 | 1% | 0% | 6 |
6 | Cell Biology | 44 | 7% | 0% | 39 |
7 | Medical Laboratory Technology | 34 | 2% | 0% | 9 |
8 | Rheumatology | 13 | 1% | 0% | 7 |
9 | Pathology | 9 | 2% | 0% | 11 |
10 | Medicine, General & Internal | 8 | 4% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MYELOMA THER Y | 132564 | 5% | 8% | 31 |
2 | GENET MICROORGANISM BIOL ANTHROPOL EVOLUT | 102123 | 0% | 100% | 2 |
3 | HAEMATOLROYAL ADELAIDE HOSP | 102123 | 0% | 100% | 2 |
4 | CLIN THER EUT INTERNAL MED | 91908 | 1% | 60% | 3 |
5 | VANDERBILT BONE BIOL | 76194 | 2% | 15% | 10 |
6 | UNIT BONE BIOL | 71029 | 1% | 17% | 8 |
7 | IRS CSFU | 62839 | 1% | 31% | 4 |
8 | 21ST CENTRUY EXCELLENCE PROGRAM | 51061 | 0% | 100% | 1 |
9 | ABT ENDOKRINOL DIABET KNOCHENERKRANKUNGEN | 51061 | 0% | 100% | 1 |
10 | ADULT STEM CE | 51061 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF HAEMATOLOGY | 9074 | 8% | 0% | 49 |
2 | EUROPEAN JOURNAL OF HAEMATOLOGY | 9027 | 4% | 1% | 26 |
3 | LEUKEMIA | 6900 | 5% | 0% | 32 |
4 | BLOOD | 5136 | 10% | 0% | 59 |
5 | BLOOD CANCER JOURNAL | 2762 | 1% | 1% | 4 |
6 | CLINICAL LYMPHOMA & MYELOMA | 2521 | 1% | 1% | 4 |
7 | BONE | 1945 | 3% | 0% | 16 |
8 | LEUKEMIA & LYMPHOMA | 1920 | 3% | 0% | 17 |
9 | JOURNAL OF BONE AND MINERAL RESEARCH | 1279 | 2% | 0% | 13 |
10 | LEUKEMIA RESEARCH | 1198 | 2% | 0% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYELOMA BONE DISEASE | 658313 | 3% | 68% | 19 | Search MYELOMA+BONE+DISEASE | Search MYELOMA+BONE+DISEASE |
2 | MULTIPLE MYELOMA | 341703 | 37% | 3% | 219 | Search MULTIPLE+MYELOMA | Search MULTIPLE+MYELOMA |
3 | BONE DISEASE | 288041 | 8% | 12% | 46 | Search BONE+DISEASE | Search BONE+DISEASE |
4 | COLLAGEN DERIVED PEPTIDES | 153184 | 1% | 100% | 3 | Search COLLAGEN+DERIVED+PEPTIDES | Search COLLAGEN+DERIVED+PEPTIDES |
5 | MYELOMA | 139955 | 12% | 4% | 70 | Search MYELOMA | Search MYELOMA |
6 | MM INDUCED BONE DISEASE | 102123 | 0% | 100% | 2 | Search MM+INDUCED+BONE+DISEASE | Search MM+INDUCED+BONE+DISEASE |
7 | OSTEOCLAST | 77267 | 14% | 2% | 84 | Search OSTEOCLAST | Search OSTEOCLAST |
8 | OSTEOLYTIC BONE DISEASE | 68076 | 1% | 33% | 4 | Search OSTEOLYTIC+BONE+DISEASE | Search OSTEOLYTIC+BONE+DISEASE |
9 | 1D11 | 51061 | 0% | 100% | 1 | Search 1D11 | Search 1D11 |
10 | 5 ALKYL SUBSTITUTED 4 THIAZOLIDINONES | 51061 | 0% | 100% | 1 | Search 5+ALKYL+SUBSTITUTED+4+THIAZOLIDINONES | Search 5+ALKYL+SUBSTITUTED+4+THIAZOLIDINONES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YACCOBY, S , (2010) ADVANCES IN THE UNDERSTANDING OF MYELOMA BONE DISEASE AND TUMOUR GROWTH.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 149. ISSUE 3. P. 311 -321 | 62 | 64% | 31 |
2 | FOWLER, JA , EDWARDS, CM , CROUCHER, PI , (2011) TUMOR-HOST CELL INTERACTIONS IN THE BONE DISEASE OF MYELOMA.BONE. VOL. 48. ISSUE 1. P. 121-128 | 58 | 67% | 22 |
3 | ZANGARI, M , SUVA, LJ , (2016) THE EFFECTS OF PROTEASOME INHIBITORS ON BONE REMODELING IN MULTIPLE MYELOMA.BONE. VOL. 86. ISSUE . P. 131 -138 | 49 | 62% | 2 |
4 | SILBERMANN, R , ROODMAN, GD , (2013) MYELOMA BONE DISEASE: PATHOPHYSIOLOGY AND MANAGEMENT.JOURNAL OF BONE ONCOLOGY. VOL. 2. ISSUE 2. P. 59-69 | 70 | 52% | 5 |
5 | SANDERSON, RD , EPSTEIN, J , (2009) MYELOMA BONE DISEASE.JOURNAL OF BONE AND MINERAL RESEARCH. VOL. 24. ISSUE 11. P. 1783-1788 | 48 | 75% | 4 |
6 | ZANGARI, M , TERPOS, E , ZHAN, FH , TRICOT, G , (2012) IMPACT OF BORTEZOMIB ON BONE HEALTH IN MYELOMA: A REVIEW OF CURRENT EVIDENCE.CANCER TREATMENT REVIEWS. VOL. 38. ISSUE 8. P. 968-980 | 50 | 58% | 18 |
7 | ROODMAN, GD , (2008) NOVEL TARGETS FOR MYELOMA BONE DISEASE.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 12. ISSUE 11. P. 1377-1387 | 50 | 67% | 16 |
8 | ACCARDI, F , TOSCANI, D , BOLZONI, M , PALMA, BD , AVERSA, F , GIULIANI, N , (2015) MECHANISM OF ACTION OF BORTEZOMIB AND THE NEW PROTEASOME INHIBITORS ON MYELOMA CELLS AND THE BONE MICROENVIRONMENT: IMPACT ON MYELOMA-INDUCED ALTERATIONS OF BONE REMODELING.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 57 | 48% | 2 |
9 | QIANG, YW , HEUCK, CJ , SHAUGHNESSY, JD , BARLOGIE, B , EPSTEIN, J , (2012) PROTEASOME INHIBITORS AND BONE DISEASE.SEMINARS IN HEMATOLOGY. VOL. 49. ISSUE 3. P. 243-248 | 42 | 66% | 8 |
10 | ABE, M , (2011) TARGETING THE INTERPLAY BETWEEN MYELOMA CELLS AND THE BONE MARROW MICROENVIRONMENT IN MYELOMA.INTERNATIONAL JOURNAL OF HEMATOLOGY. VOL. 94. ISSUE 4. P. 334-343 | 51 | 52% | 27 |
Classes with closest relation at Level 1 |